ZIM LABORATORIES LIMITED

ZIM LABORATORIES LIMITED We offer both pharmaceutical and nutraceutical products.

We are research driven pharmaceutical company who develop, manufacture and supply differentiated generic products in the oral solid dosage forms, both as pre-formulation intermediates as well as finished formulation for certain key therapeutic segments. We have in-house R&D capabilities to offer a range of non-infringing drug delivery solutions based on process technologies that bring patient compliance thereby reducing the cost of treatment.

Hotter climates are tightening the margin for error in pharmaceutical development.Rising temperature and humidity fluctu...
16/02/2026

Hotter climates are tightening the margin for error in pharmaceutical development.

Rising temperature and humidity fluctuations aren’t just an environmental issue, they’re also a pharmaceutical challenge. They affect API stability, shelf life expectations, and real-world performance across markets. Formulation decisions made early can determine resilience later.

To explore how manufacturers are addressing climate-related stress, connect with us. Reach out to us through the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Quality and safety standards set the foundation for trust in dietary supplements. Accreditation to NSF/ANSI 455-2 ensure...
13/02/2026

Quality and safety standards set the foundation for trust in dietary supplements. Accreditation to NSF/ANSI 455-2 ensures that manufacturing processes, documentation, and supply chain practices meet globally recognized benchmarks.

Working with an accredited CDMO
Reduces risk
Streamlines inspections
Signals reliability to regulators and retailers alike

To explore partnership with us, click on the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical

Dose variability does not begin at the finished product stage. It’s built in from day one.It is caused by formulation de...
11/02/2026

Dose variability does not begin at the finished product stage. It’s built in from day one.

It is caused by formulation design, process controls, analytical rigor, and scale-up discipline.

Consistency across batches demands systems that anticipate variation rather than react to it.

If dosage reliability is a priority, the right manufacturing partner matters.

Explore partnership with us through the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Notice is hereby given that pursuant to SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated 30th January, 2...
09/02/2026

Notice is hereby given that pursuant to SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated 30th January, 2026, a Special Window is now open for a period of one year from 05th February, 2026 to 04th February, 2027 for re-lodgement of transfer deeds which were lodged prior to the deadline of April 1, 2019 and rejected/returned due to deficiency in the documents may
be re-lodged with requisite documents by the shareholders of the company.

All approved transfers will be processed in demat mode only. Shareholders are advised to ensure they have an active demat account and submit the necessary supporting documents to MUFG Intime India Private Limited (Registrar and Share Transfer Agent) of the company.

We encourage eligible shareholders to utilize this opportunity within the specified timeline.

For assistance, please contact the RTA or refer to the official communication portal.

The best therapy in the world also fails if the patient can’t take it. Administration challenges often surface outside c...
09/02/2026

The best therapy in the world also fails if the patient can’t take it. Administration challenges often surface outside controlled environments. Swallowing difficulty, patient anxiety, and compliance gaps can undermine otherwise sound therapies.

Dosage formats that dissolve without effort address a real, under-discussed risk in patient care.

Explore formats designed for safer, simpler administration across patient groups with us. Click on the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Regulatory definitions for dietary supplements vary widely across regions. What qualifies as a supplement in one market ...
06/02/2026

Regulatory definitions for dietary supplements vary widely across regions. What qualifies as a supplement in one market may be treated differently in another, impacting labeling, claims, and approvals.

Partner with us to navigate international regulatory requirements with confidence. Click on the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Committed to advancing awareness, research, and responsible care. This World Cancer Day, we stand united and strong in t...
04/02/2026

Committed to advancing awareness, research, and responsible care. This World Cancer Day, we stand united and strong in the global fight against cancer.

Global expansion brings regulatory complexity. That hits after product decisions are already locked in, i.e. definitions...
02/02/2026

Global expansion brings regulatory complexity. That hits after product decisions are already locked in, i.e. definitions, approval pathways, and labelling expectations shift across regions, affecting timelines, claims, and market readiness.

An expert CDMO can help you with early regulatory alignment. Get in touch with us to know more. Click on the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Time-sensitive therapies place pressure on formulation choices long before clinical outcomes are measured.From absorptio...
30/01/2026

Time-sensitive therapies place pressure on formulation choices long before clinical outcomes are measured.

From absorption pathway to mucosal compatibility and dissolution speed all influence how quickly a dose delivers impact.

Sublingual formats are increasingly evaluated where speed and predictability are critical.

Let’s have a focused discussion on how we can help you. Reach out to us through the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Committed to responsibility, every step of the way.Happy Republic Day 🇮🇳
26/01/2026

Committed to responsibility, every step of the way.
Happy Republic Day 🇮🇳

Sublingual delivery represents a rethinking of how we approach drug performance. By enabling faster systemic entry and g...
23/01/2026

Sublingual delivery represents a rethinking of how we approach drug performance. By enabling faster systemic entry and greater predictability in absorption, it’s expanding therapeutic possibilities for molecules once limited by oral or parenteral constraints.

As research advances, this route is paving the way for smarter, patient-centered drug design.

To explore sublingual delivery for your formulations, reach out through the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Achieving predictable retention and release in oromucosal films begins with polymer science. The choice of mucoadhesive ...
21/01/2026

Achieving predictable retention and release in oromucosal films begins with polymer science. The choice of mucoadhesive matrix defines how effectively a film anchors to the mucosa, sustains drug contact, and supports controlled absorption through submucosal pathways.

This precision matters for therapeutic consistency, especially in pain management, CNS disorders, and hormone delivery, where dosing control is critical.

Explore how advanced film design is shaping the next generation of oromucosal therapies. Reach out to us through the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Address

B-21/22, MIDC Area, Kalameshwar
Nagpur
441501

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm
Saturday 9am - 5:30pm
Sunday 9am - 5:30pm

Telephone

07118271370

Website

Alerts

Be the first to know and let us send you an email when ZIM LABORATORIES LIMITED posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category